Brain Mind & Memory Institute

18/08/2025

https://www.facebook.com/share/p/1E7pvMKRPh/?mibextid=wwXIfr

2025 Conference and Workshops will be held:
1-2 November 2025
Mercure Hotel, Sydney Australia

Watch this space for more information on the programme, networking events and exciting workshop content!

ANSA's annual conference allows us to connect with members and guests providing high-quality international and local speakers; assisting ongoing professional development and networking opportunities; and catching up with sponsors as without their support we could not be providers of neuromodulation techniques.

You will have an opportunity to meet with and learn from the best professionals in the field, discuss a few case studies, and exchange assessment and treatment protocols when working with children with neurodevelopmental disorders, especially those with co-morbid presentations.

Call for Contributions
Abstract submissions for the upcoming ANSA 2025 conference are now open!
We are pleased to invite abstract submissions for our upcoming annual conference event. The 2025 ANSA
conference is an in-person event in Sydney, Australia, which will explore this year’s conference theme:
Enhancing Brain Performance Through Neuromodulation
Our exciting programme will include a host of local presenters as well as international keynote presentations
and workshops.
With a mix of in-person and remote options for presenters, we invite a range of presentations from
researcher, practitioners and other professionals, to inspire and enrich the learning of conference
participants in the applied neuroscience field. In addition, we welcome submissions for in-person workshops,
to run both before and after the Conference weekend. Selected sponsorship opportunities are also available.
You are invited to submit your proposal for participation, as we have a limited number of positions for:
a) Keynote Lecture 90 mins
b) Lecture 45 - 60 mins
c) Masterclass 2 hrs
d) Long Masterclass 3½ hrs
e) Practitioner Case Study 20 minutes
f) Workshop / Training / Practicum 1 or 2 days

Please request an application form if you are considering to present at this conference .

14/08/2025

Deep inside your brain lies the basal ganglia, a powerful network of subcortical nuclei that fine-tune everything from movement to motivation.

This network is made up of:

- Striatum: includes the caudate nucleus & putamen (dorsal striatum) + nucleus accumbens (NAc) (ventral striatum)

- Substantia nigra (SN): with two key parts that control movement & reward

- Globus pallidus (GP): regulates voluntary movement

- Ventral pallidum (VP): linked to motivation and pleasure

- Subthalamic nucleus (STN): helps inhibit unwanted movements

- Ventral tegmental area (VTA): central to reward and reinforcement

How it works:
Information flows through the basal ganglia in parallel, specialized cortico-subcortical circuits like dedicated “brain highways” for different tasks:

1️⃣ Skeletomotor & Oculomotor Circuits - Coordinate body movement and eye motion.
2️⃣ Dorsolateral Prefrontal Circuit - Handles decision-making, working memory, and problem-solving.
3️⃣ Orbitofrontal & Anterior Cingulate Circuits - Control emotion, motivation, and goal-directed behavior.

Each circuit travels through different subregions of the basal ganglia, giving each loop its own “personality.” Together, they allow your brain to integrate movement, thought, and emotion, so you can act with purpose, precision, and motivation.

13/07/2025

A new study from that explores golf course proximity and Parkinson's disease risk has been making headlines around the country.

The population-based, case-control study, led by Barrow researcher Brittany Krzyzanowski, PhD, and published in JAMA Network Open, found the greatest risk of within one to three miles of a golf course. Effect sizes were largest in water service areas with a golf course in vulnerable groundwater regions.

The associations remained even after the researchers adjusted for age and income, which suggests there could be something more than demographics driving the relationship between course proximity and risk of , Dr. Krzyzanowski explained.

"We speculate that pesticides might play a role," she told Fox News. "However, we didn’t include data on pesticides in this study, so future research is needed to better understand what’s going on."

Read the story in Fox News at https://bar.rw/golfcoursepd.

01/07/2025

The only way to correct the problem is to fix the imbalance, not treat the symptoms.

Fix the functional imbalance and the symptoms go away. Treat the symptoms with medication— the current and most popular approach— and brain function will never improve.

Symptoms will return as soon as the medication wears off.

⭐An excerpt from the book "Disconnected Kids" by Dr. Robert Melillo
👉 https://amzn.to/3xWWBtl for all of Dr. Melillo's books on Amazon!

12/05/2025

Cognitive neuroscientists have finally clocked how to perform task-based fMRI experiments in awake babies. Now they want watch cognition take shape.

12/05/2025

Baby MRIs are changing how we think about the developing brain and could reveal why we don't remember being babies

03/05/2024

Part Two: The unconscious mind

13/03/2024

A noninvasive treatment that stimulates gamma frequency brain waves may hold promise for treating "chemo brain."

In a study of mice, researchers found that daily exposure to light and sound with a frequency of 40 hertz protected brain cells from chemotherapy-induced damage. The treatment, originally developed as a way to treat Alzheimer’s disease, also helped to prevent memory loss and impairment of other cognitive functions.

“The treatment can reduce DNA damage, reduce inflammation, and increase the number of oligodendrocytes, which are the cells that produce myelin surrounding the axons,” says Li-Huei Tsai, director of MIT’s Picower Institute for Learning and Memory and the Picower Professor in the MIT Department of Brain and Cognitive Sciences. “We also found that this treatment improved learning and memory, and enhanced executive function in the animals.”

Tsai is the senior author of the new study, which appears today in Science Translational Medicine. The paper’s lead author is TaeHyun Kim, an MIT postdoc.

https://bcs.mit.edu/news/noninvasive-treatment-chemo-brain